Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 1.

Martin, M, Holmes, FA, Ejlertsen, B et al. (32 more authors) (2017) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology, 18 (12). pp. 1688-1700. ISSN 1470-2045

This list was generated on Sun Oct 13 12:04:14 2019 BST.